Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | RHOA | P61586 | 1/20 | 0.41 |
| ▸ | TGM2 | P21980 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11303697 | 0.98 | SMN1; SMN2 (0.49) | SMN1; SMN2PKMCYP3A4NPSR1ALDH1A1 | |
| SCHEMBL4394590 | 0.85 | SMN1; SMN2 (0.42) | SMN1; SMN2PKMCYP3A4NPSR1ALDH1A1 | |
| SCHEMBL10535785 | 0.83 | TGM2 (0.43) | SMN1; SMN2PKMCYP3A4NPSR1ALDH1A1 | |
| SCHEMBL18740426 | 0.82 | PKM (0.47) | SMN1; SMN2PKMCYP3A4NPSR1ALDH1A1 | |
| SCHEMBL8597983 | 0.81 | TGM2 (0.49) | SMN1; SMN2PKMALDH1A1TGM2RAB9A | |
| SCHEMBL16166446 | 0.80 | GRK2 (0.43) | SMN1; SMN2PKMCYP3A4NPSR1ALDH1A1 | |
| SCHEMBL9298771 | 0.80 | MAOB (0.49) | SMN1; SMN2ALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL9298769 | 0.80 | MAOB (0.49) | SMN1; SMN2ALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL16166407 | 0.79 | PRSS1 (0.46) | — | |
| SCHEMBL11726671 | 0.79 | ALDH1A1 (0.44) | SMN1; SMN2PKMALDH1A1TSHRRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1558 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020051701-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PATHOGENIC NEISSERIA | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2020-03-19 | — | — | WO | claimed |
| US-5604256-A | (7-(5-(1,3-DIOXANE-5YL)METHOXYIMINO-2-METHYL-8-(2-METHYLBUTYR -OXY)3-OXO-1,2,3,5,6,7,8,8A-OCTAHYDRO-1-NAPHTHYL)-3-HYDROXY-5 -OXOHEPTANOIC ACID AND SALTS | SANKYO COMPANY, LIMITED (JP) | 1997-02-18 | — | — | US | claimed |
| US-4866093-A | INHIBITING CHOLESTEROL BIOSYNTHESIS IN THE LIVER | SANKYO COMPANY LIMITED (JP) | 1989-09-12 | — | — | US | claimed |
| US-4820865-A | INHIBITORS OF BIOSYNTHESIS OF CHOLESTEROL | SANKYO COMPANY, LIMITED (JP) | 1989-04-11 | — | — | US | claimed |
| US-4695587-A | CHOLESTEROL BIOSYNTHESIS INHIBITORS | SANKYO COMPANY LIMITED (JP) | 1987-09-22 | — | — | US | claimed |
| EP-0076601-B1 | OCTAHYDRONAPHTHALENE DERIVATIVES AND THEIR PREPARATION | SANKYO COMPANY LIMITED (JP) | 1986-04-09 | — | — | EP | claimed |
| EP-0065835-B1 | M-4 AND ISO M-4 DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | SANKYO COMPANY LIMITED (JP) | 1985-11-13 | — | — | EP | claimed |
| EP-0065843-B1 | NEW M-4 AND ISO M-4 DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | SANKYO COMPANY LIMITED (JP) | 1985-09-18 | — | — | EP | claimed |
| EP-0074222-B1 | MB-530B DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SANKYO COMPANY LIMITED (JP) | 1985-04-10 | — | — | EP | claimed |
| EP-0076601-A1 | Octahydronaphthalene derivatives and their preparation | SANKYO COMPANY LIMITED (JP) | 1983-04-13 | — | — | EP | claimed |
| EP-0074222-A1 | MB-530B derivatives, their preparation and pharmaceutical compositions containing them | SANKYO COMPANY LIMITED (JP) | 1983-03-16 | — | — | EP | claimed |
| EP-0070649-A2 | ML-236B Derivatives, a process for their preparation and pharmaceutical compositions containing them | SANKYO COMPANY LIMITED (JP) | 1983-01-26 | — | — | EP | claimed |
| EP-0065835-A1 | M-4 and iso M-4 derivatives, their preparation and compositions containing them | SANKYO COMPANY LIMITED (JP) | 1982-12-01 | — | — | EP | claimed |
| EP-0065843-A1 | New M-4 and iso M-4 derivatives, their preparation and compositions containing them | SANKYO COMPANY LIMITED (JP) | 1982-12-01 | — | — | EP | claimed |
| US-4337352-A | SALT FORMATION WITH OPTICALLY ACTIVE AMINE | BAYER AKTIENGESELLSCHAFT (DE) | 1982-06-29 | — | — | US | claimed |
| EP-4398924-A1 | TRANSMEMBRANE PEPTIDIC ANTAGONISTS OF PLEXIN-A1 AND THEIR THERAPEUTIC USES | Université de Strasbourg (FR) | 2024-07-17 | — | — | EP | disclosed |
| EP-4400168-A2 | ANTISENSE NUCLEIC ACIDS | Nippon Shinyaku Co., Ltd. (JP) | 2024-07-17 | — | — | EP | disclosed |
| US-4093653-A | RESOLUTION | STAMICARBON, B.V. (NL) | 1978-06-06 | — | — | US | disclosed |
| US-4036852-A | Optical resolution of phenyl-glycine amide | STAMICARBON B.V. (NL) | 1977-07-19 | — | — | US | disclosed |
| US-3971700-A | Process for the enzymatic resolution of DL-phenyl glycine amide into its optically active antipodes | STAMICARBON B.V. (NL) | 1976-07-27 | — | — | US | disclosed |